title: The need for continuous immunosuppression with cyclosporin A to maintain an experimental model of uveal melanoma.
abstract: We investigated the need for continuous immunosuppression to maintain experimental tumours derived from human uveal melanoma cells implanted in the choroid of pigmented rabbits. Two groups of pigmented rabbits immunosuppressed with cyclosporin A (CsA) were implanted with human uveal melanoma cells in the suprachoroidal space. After 5 weeks, CsA was discontinued in group 2. Animals were treated with prophylactic antibiotics and examined weekly for tumour growth, weight and secondary effects; blood urea nitrogen levels were measured every two weeks. Autopsies and histopathological studies were performed after death or euthanasia at the end of week 12. The difference between the groups in the development of ophthalmoscopic tumours was not statistically significant 5 weeks after implantation. Tumours in group 1 grew progressively throughout the experiment, whereas group 2 tumours showed marked regression 3-4 weeks after discontinuing CsA. Tumours in group 1 were significantly larger and had greater mitotic activity and showed more ciliary body, optic nerve and extrascleral invasion than tumours in group 2, which showed massive fibrosis, minimal mitotic activity and marked inflammatory cell infiltration. Continuous immunosuppression with CsA seems to be necessary to maintain tumour growth in this experimental model of uveal melanoma.
authors.affiliation: Ocular Oncology Unit, Instituto Universitario de Oftalmobiologia Aplicada, Valladolid, Spain. jose@ioba.med.uva.es
authors.forename: J L
authors.initials: JL
authors.lastname: Ordoñez
authors.forename: M A
authors.initials: MA
authors.lastname: Saornil
authors.forename: E
authors.initials: E
authors.lastname: Domingo
authors.forename: G
authors.initials: G
authors.lastname: Blanco
authors.forename: Y
authors.initials: Y
authors.lastname: Diebold
authors.forename: A
authors.initials: A
authors.lastname: Morilla-Grasa
authors.forename: R
authors.initials: R
authors.lastname: Lopez
authors.forename: G
authors.initials: G
authors.lastname: Rabano
authors.forename: N
authors.initials: N
authors.lastname: Fernández
authors.forename: A
authors.initials: A
authors.lastname: Mayo-Iscar
mesh_terms: D000818:Animals; D001835:Body Weight / Q000187:drug effects; D016572:Cyclosporine / Q000494:pharmacology*; D004195:Disease Models, Animal; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D008297:Male; D008545:Melanoma / Q000188:drug therapy / Q000276:immunology*; D008938:Mitosis; D009374:Neoplasms, Experimental; D011817:Rabbits; D013997:Time Factors; D014407:Tumor Cells, Cultured; D014602:Uvea / Q000187:drug effects / Q000473:pathology; D014604:Uveal Neoplasms / Q000188:drug therapy / Q000276:immunology*
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine